Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Enovis Corp (ENOV)

Enovis Corp (ENOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,536,096
  • Shares Outstanding, K 57,189
  • Annual Sales, $ 2,108 M
  • Annual Income, $ -825,490 K
  • EBIT $ 76 M
  • EBITDA $ 1,011 M
  • 60-Month Beta 1.52
  • Price/Sales 0.71
  • Price/Cash Flow 1.37
  • Price/Book 0.74

Options Overview Details

View History
  • Implied Volatility 64.61% (+2.24%)
  • Historical Volatility 44.90%
  • IV Percentile 63%
  • IV Rank 52.91%
  • IV High 86.15% on 08/05/25
  • IV Low 40.40% on 03/26/25
  • Expected Move (DTE 22) 2.74 (10.19%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 130
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 8,243
  • Open Int (30-Day) 9,091
  • Expected Range 24.12 to 29.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.81
  • Number of Estimates 2
  • High Estimate 0.81
  • Low Estimate 0.81
  • Prior Year 0.98
  • Growth Rate Est. (year over year) -17.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.52 +5.25%
on 12/16/25
30.93 -13.16%
on 12/01/25
-2.74 (-9.26%)
since 11/24/25
3-Month
25.52 +5.25%
on 12/16/25
34.28 -21.65%
on 10/27/25
-4.40 (-14.08%)
since 09/24/25
52-Week
25.47 +5.48%
on 08/04/25
49.38 -45.61%
on 01/27/25
-17.09 (-38.89%)
since 12/24/24

Most Recent Stories

More News
Why Enovis (ENOV) Stock Is Trading Up Today

Why Enovis (ENOV) Stock Is Trading Up Today

ENOV : 26.86 (+2.09%)
1 Volatile Stock for Long-Term Investors and 2 We Turn Down

1 Volatile Stock for Long-Term Investors and 2 We Turn Down

ENOV : 26.86 (+2.09%)
COLB : 28.62 (+0.03%)
HUBB : 456.28 (+0.08%)
3 Stocks Under $50 That Fall Short

3 Stocks Under $50 That Fall Short

ENOV : 26.86 (+2.09%)
CRI : 31.71 (+0.06%)
MRNA : 32.75 (+1.42%)
3 Small-Cap Stocks We Find Risky

3 Small-Cap Stocks We Find Risky

ENOV : 26.86 (+2.09%)
LNC : 46.01 (+0.52%)
MHK : 110.03 (+1.01%)
Enovis, AMN Healthcare Services, Astrana Health, U.S. Physical Therapy, and AdaptHealth Stocks Trade Up, What You Need To Know

Enovis, AMN Healthcare Services, Astrana Health, U.S. Physical Therapy, and AdaptHealth Stocks Trade Up, What You Need To Know

ENOV : 26.86 (+2.09%)
USPH : 80.24 (+0.30%)
AMN : 16.01 (+0.13%)
ASTH : 25.12 (+2.78%)
AHCO : 10.24 (+1.29%)
1 Cash-Producing Stock Worth Investigating and 2 We Turn Down

1 Cash-Producing Stock Worth Investigating and 2 We Turn Down

ENOV : 26.86 (+2.09%)
MKC : 68.88 (-0.03%)
ELF : 79.76 (+1.66%)
3 Reasons to Avoid ENOV and 1 Stock to Buy Instead

3 Reasons to Avoid ENOV and 1 Stock to Buy Instead

ENOV : 26.86 (+2.09%)
The 5 Most Interesting Analyst Questions From Enovis’s Q3 Earnings Call

The 5 Most Interesting Analyst Questions From Enovis’s Q3 Earnings Call

ENOV : 26.86 (+2.09%)
Q3 Earnings Outperformers: Enovis (NYSE:ENOV) And The Rest Of The Medical Devices & Supplies - Specialty Stocks

Q3 Earnings Outperformers: Enovis (NYSE:ENOV) And The Rest Of The Medical Devices & Supplies - Specialty Stocks

ENOV : 26.86 (+2.09%)
Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know

Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know

ENOV : 26.86 (+2.09%)
CORT : 83.59 (+1.95%)
LNTH : 66.68 (+0.23%)
EVH : 4.13 (-0.72%)
RGEN : 165.66 (-0.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.

See More

Key Turning Points

3rd Resistance Point 27.39
2nd Resistance Point 27.14
1st Resistance Point 27.00
Last Price 26.86
1st Support Level 26.61
2nd Support Level 26.36
3rd Support Level 26.22

See More

52-Week High 49.38
Fibonacci 61.8% 40.24
Fibonacci 50% 37.42
Fibonacci 38.2% 34.60
Last Price 26.86
52-Week Low 25.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar